November 22nd 2024
On the most recent episode of Over the Counter, James Rider, PharmD, joined Drug Topics to discuss his career journey as a chain pharmacist.
Medication reconciliation important to avoid errors
August 16th 2012It’s important to put processes in place to be sure a patient’s medication list at discharge from the hospital is the same information that is provided to the primary care physician to avoid medication errors, according to a recent study published online July 24 in The Annals of Pharmacotherapy.
FDA warns of possible fatalities from codeine use in some children after surgical procedures
August 15th 2012FDA has issued a Drug Safety Communication concerning three children who died and one child who experienced a nonfatal but life-threatening case of respiratory depression after taking the pain-reliever codeine following tonsillectomy and/or adenoidectomy.
Generics saved Americans $1 trillion over 10 years
August 14th 2012The use of generic prescription drugs instead of their brand-name counterparts has saved Americans and the nation’s healthcare system $1.07 trillion over 10 years ending in 2011, according to the results of a study commissioned by the Generic Pharmaceutical Association.
FDA grants accelerated approval for treatment of rare type of leukemia
August 10th 2012FDA has approved vincristine sulfate liposome injection for the treatment of adult patients with Philadelphia chromosome negative (Ph-) acute lymphoblastic leukemia (ALL) who have had at least two relapses or whose disease has progressed following two or more anti-leukemia therapies.
ACA means ups, downs for various stakeholders in the generics game
August 10th 2012That the Supreme Court upheld the Affordable Care Act bodes well for the generic drug market, which is already growing by leaps and bounds annually. Industry consultants expect ACA implementation to notably benefit retail pharmacists, PBMs, and drug wholesalers.
Controlled substances: Progress in technology and e-prescribing
August 10th 2012DEA published its interim final rule on e-prescribing for controlled substances (EPCS) more than two years ago. While vendors work toward compliance, nationwide deployment of EPCS can only occur once both state and federal laws are aligned in all jurisdictions.